Innovation Pharmaceuticals News and Activities
Executives
View the org chart displaying its 4 main executives
Most searched biographies at Innovation Pharmaceuticals
- Leo Ehrlich, Chief Executive Officer, Chief Financial Officer and ...
- Barry Schechter, Independent Board Member
- Zorik Spektor, Independent Board Member
Create your alert
to follow the executive moves at Innovation Pharmaceuticals.
Biotechnology
Innovation Pharmaceuticals has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Innovation Pharmaceuticals
- Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases — Innovation Pharmaceuticals Inc.
- Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals’ Brilacidin Antifungal Research Published in Nature Communications — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis — Innovation Pharmaceuticals Inc.
- Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family — Innovation Pharmaceuticals Inc.
- Scientific Poster on Innovation Pharmaceuticals’ Brilacidin to be Presented at 2022 Chemical and Biological Defense Science & Technology Conference — Innovation Pharmaceuticals Inc.
- View more press releases Close
Social media about Innovation Pharmaceuticals
- Innovation Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Innovation Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
